Chengdu Easton (China) Performance
| 688513 Stock | 30.87 0.41 1.35% |
The firm shows a Beta (market volatility) of -0.2, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Chengdu Easton are expected to decrease at a much lower rate. During the bear market, Chengdu Easton is likely to outperform the market. At this point, Chengdu Easton Bioph has a negative expected return of -0.0909%. Please make sure to confirm Chengdu Easton's coefficient of variation, jensen alpha, and the relationship between the mean deviation and standard deviation , to decide if Chengdu Easton Bioph performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Chengdu Easton Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Chengdu Easton is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Forward Dividend Yield 0.019 | Payout Ratio 0.4068 | Last Split Factor 1.47:1 | Forward Dividend Rate 0.58 | Ex Dividend Date 2024-07-01 |
1 | Chengdu Chipscreen Pharmaceutical divulges new PRMT5 inhibitors - BioWorld Online | 02/20/2025 |
| Begin Period Cash Flow | 821.9 M |
Chengdu |
Chengdu Easton Relative Risk vs. Return Landscape
If you would invest 3,273 in Chengdu Easton Biopharmaceuticals on November 28, 2024 and sell it today you would lose (186.00) from holding Chengdu Easton Biopharmaceuticals or give up 5.68% of portfolio value over 90 days. Chengdu Easton Biopharmaceuticals is generating negative expected returns and assumes 1.4178% volatility on return distribution over the 90 days horizon. Simply put, 12% of stocks are less volatile than Chengdu, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Chengdu Easton Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chengdu Easton's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chengdu Easton Biopharmaceuticals, and traders can use it to determine the average amount a Chengdu Easton's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0641
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 688513 |
Estimated Market Risk
| 1.42 actual daily | 12 88% of assets are more volatile |
Expected Return
| -0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Chengdu Easton is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chengdu Easton by adding Chengdu Easton to a well-diversified portfolio.
Chengdu Easton Fundamentals Growth
Chengdu Stock prices reflect investors' perceptions of the future prospects and financial health of Chengdu Easton, and Chengdu Easton fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chengdu Stock performance.
| Return On Equity | 0.0952 | ||||
| Return On Asset | 0.034 | ||||
| Profit Margin | 0.19 % | ||||
| Operating Margin | 0.25 % | ||||
| Current Valuation | 4.13 B | ||||
| Shares Outstanding | 176.53 M | ||||
| Price To Book | 2.01 X | ||||
| Price To Sales | 4.11 X | ||||
| Revenue | 1.12 B | ||||
| Gross Profit | 1.01 B | ||||
| EBITDA | 263.16 M | ||||
| Net Income | 226.57 M | ||||
| Total Debt | 180.95 M | ||||
| Book Value Per Share | 15.36 X | ||||
| Cash Flow From Operations | 275.25 M | ||||
| Earnings Per Share | 1.43 X | ||||
| Total Asset | 3.35 B | ||||
| Retained Earnings | 979.58 M | ||||
About Chengdu Easton Performance
By analyzing Chengdu Easton's fundamental ratios, stakeholders can gain valuable insights into Chengdu Easton's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Chengdu Easton has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Chengdu Easton has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Chengdu Easton is entity of China. It is traded as Stock on SHG exchange.Things to note about Chengdu Easton Bioph performance evaluation
Checking the ongoing alerts about Chengdu Easton for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Chengdu Easton Bioph help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Chengdu Easton Bioph generated a negative expected return over the last 90 days | |
| About 55.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Chengdu Chipscreen Pharmaceutical divulges new PRMT5 inhibitors - BioWorld Online |
- Analyzing Chengdu Easton's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chengdu Easton's stock is overvalued or undervalued compared to its peers.
- Examining Chengdu Easton's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chengdu Easton's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chengdu Easton's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chengdu Easton's stock. These opinions can provide insight into Chengdu Easton's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Chengdu Stock analysis
When running Chengdu Easton's price analysis, check to measure Chengdu Easton's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chengdu Easton is operating at the current time. Most of Chengdu Easton's value examination focuses on studying past and present price action to predict the probability of Chengdu Easton's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chengdu Easton's price. Additionally, you may evaluate how the addition of Chengdu Easton to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |